Surgery
Volume 146, Issue 6 , Pages 1116-1122 , December 2009

Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism

  • Nancy D. Perrier, MD

      Affiliations

    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationReprint requests: Nancy D. Perrier, MD, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402.
    • ,
  • Dave Balachandran, MD

      Affiliations

    • Department of Pulmonary Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Jeffrey S. Wefel, PhD

      Affiliations

    • Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Camilo Jimenez, MD

      Affiliations

    • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Naifa Busaidy, MD

      Affiliations

    • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • George S. Morris, PhD

      Affiliations

    • Department of Rehabilitation/Physical Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Wenli Dong

      Affiliations

    • Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Edward Jackson, PhD

      Affiliations

    • Department of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Storm Weaver

      Affiliations

    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Swaroop Gantela, MD

      Affiliations

    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Douglas B. Evans, MD

      Affiliations

    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Elizabeth G. Grubbs, MD

      Affiliations

    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Jeffrey E. Lee, MD

      Affiliations

    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

,Accepted 25 September 2009.

References 

  1. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302:189–193
  2. Bilezikian JP. Primary hyperparathyroidism. When to observe and when to operate. Endocrinol Metab Clin North Am. 2000;29:465–478
  3. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:351–365
  4. Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005;242:642–650
  5. Euser SM, Schram MT, Hofman A, Westendorp RG, Breteler MM. Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology. 2008;19:440–447
  6. Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?. Ann Surg. 2004;239:528–535
  7. Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 2002;26:942–949
  8. Prager G, Kalaschek A, Kaczirek K, Passler C, Scheuba C, Sonneck G, et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery. 2002;132:930–935
  9. Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007;13:338–344
  10. Joborn C, Hetta J, Johansson H, Rastad J, Agren H, Akerstrom G, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg. 1988;12:476–481
  11. Numann PJ, Torppa AJ, Blumetti AE. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery. 1984;96:1119–1123
  12. Perrier ND, Coker LH, Rorie KD, Burbank NS, Kirkland KA, Passmore LV, et al. Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg. 2006;30:686–696
  13. Roberts KL, Hall DA. Examining a supramodal network for conflict processing: a systematic review and novel functional magnetic resonance imaging data for related visual and auditory Stroop tasks. J Cogn Neurosci. 2008;20:1063–1078
  14. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–545
  15. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995;
  16. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162–173
  17. Leung HC, Skudlarski P, Gatenby JC, Peterson BS, Gore JC. An event-related functional MRI study of the Stroop Color Word Interference Task. Cereb Cortex. 2000;10:552–560
  18. Talairach J, Tourneoux P. 3-dimensional proportional system: an approach to cerebral imaging. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers; 1988;
  19. Roman SA, Sosa JA, Mayes L, Desmond E, Boudourakis L, Lin R, et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery. 2005;138:1121–1128
  20. Fuleihan GE-H, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA. The parathyroid hormone circadian rhythm is truly endogenous—a general clinical research center study. J Clin Endocrinol Metab. 1997;82:281–286
  21. Safley SA, Villinger F, Jackson EH, Tucker-Burden C, Cohen C, Weber CJ. Interleukin-6 production and secretion by human parathyroids. Clin Exp Immunol. 2004;136:145–156
  22. Opp MR. Cytokines and sleep. Sleep Med Rev. 2005;9:355–364
  23. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption—a clinical research center study. J Clin Endocrinol Metab. 1996;81:3450–3454
  24. Talpos GB, Bone HG, Kleerekoper M, Phillips ER, Alam M, Honasoge M, et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 2000;128:1013–1020
  25. Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery. 2007;141:777–783
  26. Tung A, Mendelson W. Anesthesia and sleep. Sleep Medicine Reviews. 2004;8:213–225
  27. Knill RL, Moote CA, Rose EA. Anesthesia with abdominal surgery lead to intense REM sleep during the first postoperative week. Anesthesiology. 1990;73:52–61
  28. Moote CA, Knill RL. Isoflorane anesthesia causes a transient alteration in nocturnal sleep. Anesthesiology. 1988;69:327–331

 Funded by the American Geriatric Society, Jahnigan Career Development Award

PII: S0039-6060(09)00575-3

doi: 10.1016/j.surg.2009.09.034

Surgery
Volume 146, Issue 6 , Pages 1116-1122 , December 2009

Article Tools

* Image Usage & Resolution